An efficacy study of itraconazole in the treatment of Penicillium marneffei infection.
Artigo
em Inglês
| IMSEAR
| ID: sea-42922
ABSTRACT
OBJECTIVES:
to evaluate the efficacy and safety of itraconazole in treating P. marneffei infection.METHODS:
Ten patients with previously untreated P. marneffei infection were given oral itraconazole at a dose of 200 mg twice a day for 2 months, followed by a dose of 100 mg once a day for 1 month. Efficacy was determined by the clinical and microbiological cure.RESULTS:
All but one patient were seropositive for human immunodeficiency virus (HIV). Two patients died during therapy. Clinical improvement was evident in 8 patients. In 7 of these, the mean duration for becoming culture negative was 57 days. Five patients presented with relapse of P. marneffei infection within four months after completion of treatment.CONCLUSIONS:
Itraconazole was shown to be effective in the initial treatment of P. marneffei infection. Relapse after treatment is common and long-term suppressive therapy is recommended.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Penicillium
/
Feminino
/
Humanos
/
Masculino
/
Adolescente
/
Soropositividade para HIV
/
Itraconazol
/
Adulto
/
Cetoconazol
/
Pessoa de Meia-Idade
Idioma:
Inglês
Ano de publicação:
1992
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS